Intarcia Therapeutics

I2 Therapeutics

This company develops oral drug delivery formulations and long-acting therapies for metabolic and inflammatory diseases to improve patient adherence and treatment efficacy.

Lymphatica Medtech

This company develops implantable medical devices designed to replace lymphatic drainage function for patients suffering from chronic lymphedema.

iRiva Medical

This company develops implantable neuromodulation technology platforms to treat patients suffering from chronic diseases.

Drug Delivery

This company develops ingestible technology for drug delivery and health monitoring to serve patients and healthcare providers.

Encellin

The company develops an encapsulated cell replacement therapy to deliver living medicines for patients with endocrine disorders such as type 1 diabetes.

Beta Bionics

This company develops an autonomous insulin delivery system for children and adults living with type 1 diabetes to manage their glucose levels.

IntrepidiaBio

This biopharmaceutical company develops therapeutic products to address unmet medical needs for patients.

Intrinsic Therapeutics

This company manufactures spinal implants for surgeons to reduce the risk of recurring disc herniations in patients undergoing discectomy procedures.